TDP2 couples PKA-CREB signalling to genome stability in human cerebellar development
En palabras de los autores
Transcription and neuronal activity in the central nervous system generate abundant DNA damage, particularly DNA double-strand breaks (DSBs), rendering neural cells - and cerebellar neurons especially - vulnerable to genome instability. Tyrosyl-DNA phosphodiesterase 2 (TDP2, also known as TTRAP) resolves topoisomerase-2-linked DSBs, and biallelic TDP2 mutations cause spinocerebellar ataxia autosomal recessive 23 (SCAR23), yet how DNA repair shapes human cerebellar development is unknown. Here we model SCAR23 in cerebellar organoids derived from patient induced pluripotent stem cells carrying TDP2 c.650del and from prime-edited isogenic TDP2 c.400C>T lines. TDP2 inactivation caused organoid hypoplasia during FGF8b-dependent cerebellar specification, which was reversed by TDP2 complementation. Single-nucleus transcriptomics across three developmental stages revealed early dysregulation of ribosome biogenesis, attenuated CREB1 regulon activity and a subsequent failure of Purkinje cell maturation. TDP2 inactivation upregulated PKIB, a cerebellum-enriched inhibitor of protein kinase A, lowering PKA and CREB phosphorylation. Whole-genome sequencing showed excess de novo deletions in mutant organoids, enriched at candidate cis-regulatory elements of neurodevelopmental genes. Pharmacological activation of the cAMP-PKA cascade restored CREB phosphorylation, reduced DNA damage and rescued organoid growth. These findings link developmental signalling to genome maintenance in the human cerebellum and identify the cAMP-PKA-CREB axis as a candidate therapeutic target in DNA-repair-deficient cerebellar disease.
Apareció: jueves, 19 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.